Vendor review
ZhuoYan lab reviews
ZhuoYan lab reviews from 52 independent lab tests (Tirzepatide, Retatrutide and Tesamorelin): grade A, purity and fill accuracy. Is ZhuoYan lab legit? See what its vials showed.
What the lab tests show
52 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Sep 30, 2026 | Retatrutide | 99.9 % | 29.99 mg of 30 mg (0 %) | Pass | View |
| Sep 18, 2026 | Tirzepatide | 99.99 % | 47.55 mg of 50 mg (-5 %) | Pass | View |
| Sep 16, 2026 | Tirzepatide | 50 mg | Fail | View | |
| Aug 13, 2026 | Tirzepatide | 50 mg | Fail | View | |
| Jul 23, 2026 | GHK-Cu | 99.5 % | 86.4 mg of 100 mg (-14 %) | Pass | View |
| Jun 8, 2026 | BPC-157 | 10 mg | Fail | View | |
| Jun 5, 2026 | Retatrutide | 99.9 % | 61.2 mg of 60 mg (2 %) | Pass | View |
| Apr 23, 2026 | Tirzepatide | 99.9 % | 30.6 mg of 30 mg (2 %) | Pass | View |
| Mar 6, 2026 | Tirzepatide | 99.9 % | 20 mg of 20 mg (0 %) | Pass | View |
| Mar 6, 2026 | GHK-Cu | 99.9 % | 92.6 mg of 100 mg (-7 %) | Pass | View |
| Feb 20, 2026 | GHK-Cu | 99.7 % | 45.3 mg of 50 mg (-9 %) | Pass | View |
| Feb 20, 2026 | Tesamorelin | 99.7 % | 14.9 mg of 10 mg (49 %) | Pass | View |
| Feb 11, 2026 | Retatrutide | 99.9 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| Feb 4, 2026 | BPC-157 | 99.5 % | 13.4 mg of 10 mg (34 %) | Pass | View |
| Jan 29, 2026 | Tirzepatide | 99.9 % | 56.2 mg of 50 mg (12 %) | Pass | View |
| Jan 29, 2026 | Tirzepatide | 99.9 % | 9.78 mg of 10 mg (-2 %) | Pass | View |
| Jan 29, 2026 | Tesamorelin | 10 mg | Fail | View | |
| Jan 29, 2026 | Tesamorelin | 97.46 % | 8.49 mg of 10 mg (-15 %) | Pass | View |
| Jan 19, 2026 | Tirzepatide | 99.95 % | 15.6 mg of 15 mg (4 %) | Pass | View |
| Jan 15, 2026 | Tirzepatide | 99.7 % | 117.8 mg of 100 mg (18 %) | Pass | View |
| Jan 15, 2026 | Tirzepatide | 99.8 % | 11.5 mg of 10 mg (15 %) | Pass | View |
| Jan 15, 2026 | Retatrutide | 99.7 % | 19.7 mg of 20 mg (-2 %) | Pass | View |
| Jan 1, 2026 | Tirzepatide | 99.9 % | 48 mg of 50 mg (-4 %) | Pass | View |
| Jan 1, 2026 | Tirzepatide | 99.8 % | 53.1 mg of 50 mg (6 %) | Pass | View |
| Dec 17, 2025 | GHK-Cu | 99.95 % | 56.1 mg of 50 mg (12 %) | Pass | View |
| Dec 17, 2025 | Retatrutide | 99.89 % | 40.9 mg of 40 mg (2 %) | Pass | View |
| Dec 17, 2025 | Tesamorelin | 98.01 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| Dec 17, 2025 | Ipamorelin | 98.72 % | 5.3 mg of 5 mg (6 %) | Pass | View |
| Dec 13, 2025 | Tirzepatide | 99.7 % | 35.2 mg of 30 mg (17 %) | Pass | View |
| Dec 13, 2025 | Retatrutide | 99.5 % | 23.5 mg of 20 mg (18 %) | Pass | View |
| Nov 25, 2025 | Retatrutide | 99.95 % | 20.3 mg of 20 mg (2 %) | Pass | View |
| Nov 25, 2025 | Tesamorelin | 65.36 % | 7.77 mg of 10 mg (-22 %) | Pass | View |
| Nov 17, 2025 | Tirzepatide | 99.95 % | 15.3 mg of 15 mg (2 %) | Pass | View |
| Nov 14, 2025 | Retatrutide | 99.7 % | 10.9 mg of 10 mg (9 %) | Pass | View |
| Nov 14, 2025 | Retatrutide | 99.6 % | 69.8 mg of 60 mg (16 %) | Pass | View |
| Nov 14, 2025 | Ipamorelin | 99.9 % | 5.5 mg of 5 mg (10 %) | Pass | View |
| Nov 4, 2025 | Tirzepatide | 99.95 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| Oct 21, 2025 | Retatrutide | 99.67 % | 9.84 mg of 10 mg (-2 %) | Pass | View |
| Oct 9, 2025 | Retatrutide | 99.57 % | 29 mg of 30 mg (-3 %) | Pass | View |
| Oct 7, 2025 | Tirzepatide | 98.8 % | 14.5 mg of 10 mg (45 %) | Pass | View |
| Oct 6, 2025 | Tirzepatide | 99.3 % | 24.6 mg of 20 mg (23 %) | Pass | View |
| Sep 30, 2025 | Tirzepatide | 99.92 % | 19.4 mg of 20 mg (-3 %) | Pass | View |
| Sep 18, 2025 | Tirzepatide | 99.95 % | 33.4 mg of 30 mg (11 %) | Pass | View |
| Sep 18, 2025 | Retatrutide | 99.93 % | 9.06 mg of 10 mg (-9 %) | Pass | View |
| Sep 18, 2025 | Ipamorelin | 99.04 % | 2.35 mg of 2 mg (18 %) | Pass | View |
| Aug 6, 2025 | Retatrutide | 99.56 % | 5.62 mg of 5 mg (12 %) | Pass | View |
| Aug 5, 2025 | Tirzepatide | 99.712 % | 20.56 mg of 20 mg (3 %) | Pass | View |
| Aug 5, 2025 | Tesamorelin | 98.044 % | 10.24 mg of 10 mg (2 %) | Pass | View |
| Aug 4, 2025 | Retatrutide | 99.369 % | 16.97 mg of 15 mg (13 %) | Pass | View |
| Jul 28, 2025 | Tirzepatide | 99.36 % | 19.4 mg of 20 mg (-3 %) | Pass | View |
| Jul 3, 2025 | Tirzepatide | 99.39 % | 9.68 mg of 10 mg (-3 %) | Pass | View |
| Jul 2, 2025 | Tirzepatide | 99.14 % | 4.8 mg of 5 mg (-4 %) | Pass | View |
What ZhuoYan lab sells
No current listings on record.
About ZhuoYan lab
Facebook Group